Low BUN/Creatinine Ratio and Fatty Liver Disease
A low BUN/creatinine ratio is not a diagnostic sign of fatty liver disease, but emerging evidence suggests low BUN levels may be independently associated with fatty liver and could reflect underlying metabolic changes related to the disease.
The Evidence Linking Low BUN to Fatty Liver
The relationship between low BUN and fatty liver is supported by recent research, though this is not part of standard diagnostic guidelines:
A 2021 Japanese cross-sectional study of 56,639 participants found that serum BUN levels inversely correlated with fatty liver presence 1. Over 20 years, as fatty liver prevalence increased from 27.3% to 42.7% in men and 18.0% to 25.5% in women, BUN levels significantly decreased (from 15.8 to 14.9 mg/dL in men and 15.1 to 14.0 mg/dL in women). Low BUN was independently associated with fatty liver in both sexes (OR: 0.958 and 0.961 respectively) 1.
A 2022 study demonstrated a U-shaped relationship between urea levels and liver disease progression 2. In a cohort of 12,476 NAFLD patients followed for 9.9 years, those with urea ≤3.5 mmol/L had significantly higher risk of incident cirrhosis (adjusted HR: 1.27,95% CI: 1.03-1.57) 2.
Why This Occurs (Mechanistic Understanding)
Low BUN in fatty liver likely reflects:
- Altered nitrogen metabolism and protein synthesis in the context of hepatic steatosis
- Changes in body composition with increased visceral fat and decreased muscle mass, which reduces urea production from protein catabolism 1
- Dietary patterns associated with fatty liver (lower protein intake, higher carbohydrate consumption)
Clinical Implications and Limitations
Important Caveats:
The BUN/creatinine ratio is NOT included in any established guidelines for diagnosing or screening for NAFLD 3, 4. Current guidelines recommend:
- FIB-4 score as the first-line assessment tool for risk stratification in NAFLD, using age, ALT, AST, and platelet count 3
- Enhanced Liver Fibrosis (ELF) test or elastography as second-tier assessments 3, 4
- FIB-4 <1.3 reliably excludes advanced fibrosis with NPV of 92.7% 3
When to Consider Low BUN Clinically:
While not diagnostic, a low BUN/creatinine ratio in the context of:
- Metabolic syndrome features
- Elevated liver enzymes
- Imaging suggesting steatosis
...may support the clinical picture of fatty liver and prompt appropriate guideline-based evaluation with FIB-4 scoring and lifestyle counseling focused on cardiovascular risk reduction 4.
What Low BUN/Creatinine Ratio Actually Diagnoses:
The BUN/creatinine ratio has established utility in other conditions:
- BCR ≤12 suggests acute interstitial nephritis in AKI patients (sensitivity 76%, specificity 81%) 5
- Elevated BCR suggests upper GI bleeding 6
Do not use BUN/creatinine ratio as a screening or diagnostic tool for fatty liver disease. Instead, follow established guidelines using FIB-4 score for initial risk stratification, followed by ELF testing or elastography for indeterminate cases 3, 4.